Melanoma trial failure deals heavy blow to immunotherapy hopes – Financial Times
Financial Times |
Melanoma trial failure deals heavy blow to immunotherapy hopes
Financial Times The quest to expand the benefits of cancer immunotherapy to more patients suffered a major setback on Friday following the failure of a closely followed clinical trial. Immunotherapies work by removing brakes in the immune system so the body can attack … |
